Colgate Palmolive (CL) Invested Capital (2009 - 2025)

Colgate Palmolive's Invested Capital history runs 15 years deep, the most recent figure standing at $1.7 billion for Q1 2025.

• On a quarterly basis, Invested Capital rose 8390.0% year-over-year to $1.7 billion in Q1 2025; TTM through Dec 2025 was $1.7 billion, a 135.51% increase from a year earlier, with the FY2024 full-year figure at $660.0 million, up 3200.0% from the prior year.
• Invested Capital rose to $1.7 billion in Q1 2025 per CL's latest filing, from $660.0 million in the prior quarter.
• Across five years, Invested Capital topped out at $1.7 billion in Q1 2025 and bottomed at $9.0 million in Q1 2021.
• The 5-year median for Invested Capital is $15.0 million (2023), against an average of $151.8 million.
• Across the five-year window, Invested Capital tumbled 96.47% in 2021 and jumped 8390.0% in 2025, its largest moves.
• Year by year, Invested Capital stood at $12.0 million in 2021, then gained by 16.67% to $14.0 million in 2022, then surged by 42.86% to $20.0 million in 2023, then jumped by 3200.0% to $660.0 million in 2024, then jumped by 157.27% to $1.7 billion in 2025.
• Per Business Quant, the three latest CL Invested Capital figures stand at $1.7 billion (Q1 2025), $660.0 million (Q4 2024), and $20.0 million (Q3 2024).